These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2507817)

  • 21. [Differentiation between Mycobacterium malmoense and Mycobacterium nonchromogenicum by ethambutol susceptibility].
    Yamori S; Tsukamura M
    Kekkaku; 1989 Feb; 64(2):95-7. PubMed ID: 2733305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibilities of Mycobacterium malmoense determined at the growth optimum pH (pH 6.0).
    Heginbothom ML; Lindholm-Levy PJ; Heifets LB
    Int J Tuberc Lung Dis; 1998 May; 2(5):430-4. PubMed ID: 9613641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A rapid susceptibility test of Mycobacterium tuberculosis using hybridization protection assay].
    Miyamoto J; Koga H; Kohno S; Ohno H; Fukuda M; Ogawa K; Tomono K; Kaku M; Hara K; Hashimoto A
    Kekkaku; 1995 Jun; 70(6):377-83. PubMed ID: 7630073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.
    Cavicchioli M; Leite CQ; Sato DN; Massabni AC
    Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility testing for mycobacteria.
    Woods GL
    Clin Infect Dis; 2000 Nov; 31(5):1209-15. PubMed ID: 11073754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on drug resistance test medium of cycloserine. i. Comparison of the minimal intercepting concentrations of Mycobacterium tuberculosis on 1 percent Ogawa medium, Kirchner agar and Kirchner semi-solid agar medium].
    Tamura M; Igai S; Takano S
    Iryo; 1966 Jan; 20(1):71-5. PubMed ID: 4957725
    [No Abstract]   [Full Text] [Related]  

  • 30. [Characteristics of Mycobacteria from patients with genital tuberculosis].
    Blagodarnyĭ IaA; Alimbekova OA; Blonskaia LI
    Probl Tuberk; 1990; (1):37-41. PubMed ID: 2110667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring minimum inhibitory concentrations in mycobacteria.
    Sirgel FA; Wiid IJ; van Helden PD
    Methods Mol Biol; 2009; 465():173-86. PubMed ID: 20560078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study of INH 0.1 microgram/ml resistant M. tuberculosis strains assessed by BrothMIC MTB-1 method].
    Yoshida H; Ano H; Ishida C; Tanigawa N; Kikui M; Takashima T; Tsuyuguchi I
    Kekkaku; 2002 Jul; 77(7):533-5. PubMed ID: 12187818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of atypical mycobacteria isolated from clinical specimens by line probe assay (LIPA)].
    Biçmen C; Coşkun M; Gündüz AT; Senol G; Cirak AK; Tibet G
    Mikrobiyol Bul; 2007 Oct; 41(4):503-10. PubMed ID: 18173068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on detection of the Mycobacteria DNA in formalin-fixed, paraffin-embedded tissue samples by triplex polymerase chain reaction].
    Li Z; Qin W; Yue Q; Meng K; Lin Q
    Wei Sheng Wu Xue Bao; 2002 Feb; 42(1):69-75. PubMed ID: 12557351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
    Abate G; Koivula T; Hoffner SE
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):933-5. PubMed ID: 12365582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Negative effect of the components of the lysis-centrifugation system in the growth of mycobacteria in MGIT and Septi-Chek AFB liquid media].
    Gamboa F; de la Rosa Z; Bustillo J; Mora MP; Hernández I; Mirque F
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):439-44. PubMed ID: 11149167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro study of the susceptibility of mycobacteria to sulfonamides by the disc and percentage methods (author's transl)].
    Demoulin L; Médard M; Kellens J
    Pathol Biol (Paris); 1982 Apr; 30(4):201-5. PubMed ID: 7045778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical mycobacteriology. Drug susceptibility testing.
    Heifets LB
    Clin Lab Med; 1996 Sep; 16(3):641-56. PubMed ID: 8866184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interpretive compatibility of antimycobacterial susceptibility for Mycobacterium tuberculosis determined by proportion test method on egg-based Ogawa media and broth microdilution test, BrothMIC MTB].
    Higa M; Saitoh H; Yamane N; Nakasone I; Miyagi C
    Kekkaku; 2002 Feb; 77(2):61-6. PubMed ID: 11905029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.